Identification of Hub Genes and MicroRNAs with Prognostic Values in Esophageal Cancer by Integrated Analysis

Overview

Journal Noncoding RNA Res

Date 2023 Jul 7

PMID 37416747

Authors

Amir Mokhlesi

Zahra Sharifi

Ahmad Berimipour

Sara Taleahmad

Mahmood Talkhabi

Affiliations

Soon will be listed here.

Abstract

Esophageal cancer (EC) is the eighth most common cancer in the world, and the sixth most common cause of cancer-related mortality. The aim of the present study was to identify cell and molecular mechanisms involved in EC, and to provide the potential targets for diagnosis and treatment. Here, a microarray dataset (GSE20347) was screened to find differentially expressed genes (DEGs). Different bioinformatic methods were used to analyze the identified DEGs. The up-regulated DEGs were significantly involved in different biological processes and pathways including extracellular matrix organization and ECM-receptor interaction. FN1, CDK1, AURKA, TOP2A, FOXM1, BIRC5, CDC6, UBE2C, TTK, and TPX2 were identified as the most important genes among the up-regulated DEGs. Our analysis showed that has-miR-29a-3p, has-miR-29b-3p, has-miR-29c-3p, and has-miR-767-5p had the largest number of common targets among the up-regulated DEGs. These findings strengthen the understanding of EC development and progression, as well as representing potential markers for EC diagnosis and treatment.

Citing Articles

SECTM1 acts as an immune-related biomarker of poor prognosis and promotes cancer progression by modulating M2 macrophage polarization in esophageal squamous cell carcinoma.

Kong P, Jiao Y, Sun M, Zhou Z, Zhang Y, Yang X Front Immunol. 2025; 16:1507227.

PMID: 39944684 PMC: 11814170. DOI: 10.3389/fimmu.2025.1507227.

Risk for Esophageal Cancer Based on Lifestyle Factors-Smoking, Alcohol Consumption, and Body Mass Index: Insight from a South Korean Population Study in a Low-Incidence Area.

Kwon M, Kang H, Choi H, Kim J, Kim J, Bang W J Clin Med. 2023; 12(22).

PMID: 38002698 PMC: 10672319. DOI: 10.3390/jcm12227086.

References

Li J, Li X, Kong X, Luo Q, Zhang J, Fang L . MiRNA-26b inhibits cellular proliferation by targeting CDK8 in breast cancer. Int J Clin Exp Med. 2014; 7(3):558-65. PMC: 3992393. View

Liu L, Liu L, Lu S . lncRNA H19 promotes viability and epithelial-mesenchymal transition of lung adenocarcinoma cells by targeting miR-29b-3p and modifying STAT3. Int J Oncol. 2019; 54(3):929-941. PMC: 6365046. DOI: 10.3892/ijo.2019.4695. View

Zhou S, Liu S, Lin C, Li Y, Ye L, Wu X . TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ. Oncogene. 2020; 39(18):3710-3725. DOI: 10.1038/s41388-020-1245-0. View

Rao M, Van Vleet T, Ciurlionis R, Buck W, Mittelstadt S, Blomme E . Comparison of RNA-Seq and Microarray Gene Expression Platforms for the Toxicogenomic Evaluation of Liver From Short-Term Rat Toxicity Studies. Front Genet. 2019; 9:636. PMC: 6349826. DOI: 10.3389/fgene.2018.00636. View

Fuschi P, Carrara M, Voellenkle C, Garcia-Manteiga J, Righini P, Maimone B . Central role of the p53 pathway in the noncoding-RNA response to oxidative stress. Aging (Albany NY). 2017; 9(12):2559-2586. PMC: 5764393. DOI: 10.18632/aging.101341. View

Nesteruk K, Janmaat V, Liu H, Ten Hagen T, Peppelenbosch M, Fuhler G . Forced expression of HOXA13 confers oncogenic hallmarks to esophageal keratinocytes. Biochim Biophys Acta Mol Basis Dis. 2020; 1866(8):165776. DOI: 10.1016/j.bbadis.2020.165776. View

Li J, Liang Y, Lv H, Meng H, Xiong G, Guan X . miR-26a and miR-26b inhibit esophageal squamous cancer cell proliferation through suppression of c-MYC pathway. Gene. 2017; 625:1-9. DOI: 10.1016/j.gene.2017.05.001. View

Clarke D, Kuleshov M, Schilder B, Torre D, Duffy M, Keenan A . eXpression2Kinases (X2K) Web: linking expression signatures to upstream cell signaling networks. Nucleic Acids Res. 2018; 46(W1):W171-W179. PMC: 6030863. DOI: 10.1093/nar/gky458. View

Fahrmann J, Grapov D, Wanichthanarak K, DeFelice B, Salemi M, Rom W . Integrated Metabolomics and Proteomics Highlight Altered Nicotinamide- and Polyamine Pathways in Lung Adenocarcinoma. Carcinogenesis. 2017; 38(3):271-280. PMC: 5862279. DOI: 10.1093/carcin/bgw205. View

10.

Byron S, Van Keuren-Jensen K, Engelthaler D, Carpten J, Craig D . Translating RNA sequencing into clinical diagnostics: opportunities and challenges. Nat Rev Genet. 2016; 17(5):257-71. PMC: 7097555. DOI: 10.1038/nrg.2016.10. View

11.

Chan C, Lai K, Ng E, Kiang M, Kwok T, Wang H . Serum microRNA-193b as a promising biomarker for prediction of chemoradiation sensitivity in esophageal squamous cell carcinoma patients. Oncol Lett. 2018; 15(3):3273-3280. PMC: 5778798. DOI: 10.3892/ol.2017.7698. View

12.

Hanley C, Noble F, Ward M, Bullock M, Drifka C, Mellone M . A subset of myofibroblastic cancer-associated fibroblasts regulate collagen fiber elongation, which is prognostic in multiple cancers. Oncotarget. 2015; 7(5):6159-74. PMC: 4868747. DOI: 10.18632/oncotarget.6740. View

13.

Kai F, Drain A, Weaver V . The Extracellular Matrix Modulates the Metastatic Journey. Dev Cell. 2019; 49(3):332-346. PMC: 6527347. DOI: 10.1016/j.devcel.2019.03.026. View

14.

Zhang W, Yu Y, Hertwig F, Thierry-Mieg J, Zhang W, Thierry-Mieg D . Comparison of RNA-seq and microarray-based models for clinical endpoint prediction. Genome Biol. 2015; 16:133. PMC: 4506430. DOI: 10.1186/s13059-015-0694-1. View

15.

Lin Y, Totsuka Y, Shan B, Wang C, Wei W, Qiao Y . Esophageal cancer in high-risk areas of China: research progress and challenges. Ann Epidemiol. 2016; 27(3):215-221. DOI: 10.1016/j.annepidem.2016.11.004. View

16.

Liu H, Zhang Y, Wang X, Qin W, Liu Y, Zhang L . Upregulation of the TPX2 gene is associated with enhanced tumor malignance of esophageal squamous cell carcinoma. Biomed Pharmacother. 2013; 67(8):751-5. DOI: 10.1016/j.biopha.2013.04.004. View

17.

Saddoughi S, Ogretmen B . Diverse functions of ceramide in cancer cell death and proliferation. Adv Cancer Res. 2013; 117:37-58. DOI: 10.1016/B978-0-12-394274-6.00002-9. View

18.

Du R, Li K, Zhou Z, Huang Y, Guo K, Zhang H . Bioinformatics and experimental validation of an AURKA/TPX2 axis as a potential target in esophageal squamous cell carcinoma. Oncol Rep. 2023; 49(6). PMC: 10170493. DOI: 10.3892/or.2023.8553. View

19.

Wang J, Yu P, Luo J, Sun Z, Yu J, Wang J . Transcriptomic and microRNA Expression Profiles Identify Biomarkers for Predicting Neo-Chemoradiotherapy Response in Esophageal Squamous Cell Carcinomas (ESCC). Front Pharmacol. 2021; 12:626972. PMC: 8082678. DOI: 10.3389/fphar.2021.626972. View

20.

Kamikawaji K, Seki N, Watanabe M, Mataki H, Kumamoto T, Takagi K . Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis. J Hum Genet. 2016; 61(12):985-993. DOI: 10.1038/jhg.2016.99. View